ICICI Direct Broker Research reports

About the stock: Firstsource Solutions (FSL) provides business process services to BFSI, communication, media, tech and healthcare. FSL is a domain driven BPM services company which has 200+ global clients, including several Fortune-500...

Powergrid transmits ~45% of the total power generated in India on its transmission network & owns ~84% of Inter-State transmission system. It also undertakes transmission related consultancy to more than 150...

Q2FY26 performance: DLF reported healthy pre-sales booking of 4332 crore for Q2FY26 (up 6.3x YoY, down 62.1% QoQ) led by its maiden project launch in Mumbai The Westpark ( 2316 crore) and healthy contribution from super-luxury project Camellias ( 1624 crore). However, collections were soft at 2672 crore (up 12.7% YoY, down 4.4% QoQ). Lower revenue booking led to 17% YoY decline in consolidated revenues at 1643 crore for Q2FY26. Further, gross margins and EBITDA margins were lower 222 bps and 816 bps YoY at 43.1% and 17.3%. Consolidated net profit of 1180 crore (down 15% YoY, up 55% QoQ) was aided by...

About the stock: Arvind Fashions Ltd. (AFL) is a multi-brand apparel company. The company operates high value global brands such as US Polo, Tommy Hilfiger, Arrow and Calvin Klein under license agreement while it has its own in-house leading denim brand Flying Machine. The company operates through 998 Retail...

We continue to focus on Jubilant's flagship segments such as Radiopharmaceuticals, Allergy Immunotherapy, CDMO Sterile Injectables and Drug Discovery Services which together contribute ~53% of the sales and more than 90% of the EBITDA on the back of their high-margin profile. Their performances are also critical in order to achieve the management's aspirational target for FY30 - doubling of overall revenues (FY24 base),...

Q2FY26 performance: Titan's consolidated net revenues grew by 22%yoy to Rs16,461cr (total revenues grew by 29%). This was driven by 18% growth in the domestic jewellery business, 32% growth in Caratlane and 84% growth in the international business while TEAL (subsidiary) revenues grew by 2x during the quarter. Its watches and eyewear business had a soft quarter with revenues growing by 13% and 8% in Q2. Consolidated gross margins decreased by 127bps YoY affected by higher gold prices and inferior mix. EBIDTA margins decreased by...

Advance comprises of MSME (40%) and Agri (16%) segment. Diversifying focus towards other retail segment home loan, personal loan etc. Q2FY26 performance: City Union Bank reported strong performance in Q2FY26, with PAT rising 15% YoY to 328.6 crore, aided by healthy loan growth and margin expansion. Advances grew 18% YoY to 57,561 crore, led by robust traction in MSME and retail segments, while deposits increased 21% YoY to 69,486 crore, supported by a 16% rise in CASA. NIM improved 9 bps QoQ to 3.63%, owing to moderation in the cost of deposits and a favourable change in asset mix. Other...

About the stock: Gland Pharma is one of the largest generic injectable-focused Along with its partners, Gland owns 1,748 products registrations globally of which ~490 in US, Europe, Canada, Australia, and New Zealand, ~73 in...

Q2FY26- Momentum driven by US and India Business - Revenues grew ~14% YoY to 1354 crore driven by US and India branded business which grew ~48% / ~12% to 344 crore and 432 crore, respectively. Other branded businesses such as Asia and Africa witnessed the growth of 5% / 4% (on higher base) to 310 crore and 221 crore, respectively. On the operational front, EBITDA grew 5.4% YoY to ~328 crore (excluding forex losses of 41 crore, 9 % growth to ~369 crore) with margins at 24.2%...

With healthy volume growth and significant improvement in EBITDA/ton over FY25-28E, we expect revenue & EBITDA CAGR at ~13% & ~30% respectively over the same period. We maintain BUY on Ambuja Cements with a target price of Rs 700 (based on 17x EV/EBITDA on FY27E & FY28E...